Review
Copyright ©The Author(s) 2023.
World J Virol. Jun 25, 2023; 12(3): 136-150
Published online Jun 25, 2023. doi: 10.5501/wjv.v12.i3.136
Table 1 Common viruses affecting the gastrointestinal system
Virus
Route of infection
Population affected
Type of disease
Diagnosis
Treatment
NorovirusFecal-oral, fomitesChildren < 5 yrGastroenteritisSelf-limitedSupportive
RotavirusFecal-oral, fomitesChildren < 5 yrGastroenteritisSelf-limitedSupportive
AdenovirusFecal-oral, fomitesAny age group, especially childrenGastroenteritisSelf-limitedSupportive
Hepatitis AFecal-oral, fomitesAny age groups; international travelers to endemic countries, IV drug users, men who have sex with menGastroenteritis, acute viral hepatitis, and fulminant liver failureSerologySupportive
AstrovirusFecal-oral, fomitesChildren < 5 yrGastroenteritisSelf-limitedSupportive
SapovirusFecal-oral, fomitesChildren < 5 yrGastroenteritisSelf-limitedSupportive
CoronavirusFecal-oral, fomitesAny age groupGastroenteritis; respiratory infectionSelf-limited, viral rapid antigen, PCR can be performedSupportive; for COVID-19-antivirals (nirmatrelvir/ritonavir, remdesivir), steroids, biologics (tocilizumab, baricitinib)
Hepatitis EFecal-oral, Fomites15-40 yrGastroenteritis, acute hepatitis, and acute liver failureSerologySupportive
CytomegalovirusContact with bodily fluids and organ transplantationAll agesColitis, toxic megacolon, and peritonitisViral PCRGanciclovir, valganciclovir, ganciclovir resistant-foscarnet, cidofovir
Herpes simplex virusSexual contactMSMProctitis and anal ulcerationsViral PCRAcyclovir, valacyclovir, and famciclovir
HIVContact through bodily fluids like sexual contact, injection drug use, perinatal transmissionAll agesAcquired immunodeficiency syndrome, HIV enteropathy-diarrhea2-step testing-combination antigen-antibody test followed by HIV 1/2 differentiation assayHAART-combination therapy with Tenofovir, Emtricitabine, raltegravir, and bictegravir
Hepatitis B and DContact through bodily fluids like sexual contact, injection drug use, perinatal transmissionUsually adults, but all age groups can be affectedHepatitis, cirrhosis, hepatocellular carcinomaSerology, DNA loadAcute infections usually resolve; in some cases, tenofovir, entecavir
Hepatitis CContact through bodily fluids like sexual contact, injection drug use, transfusion, or perinatal transmissionUsually adults, but all age groups can be affectedHepatitis, cirrhosis, hepatocellular carcinomaSerology, RNA loadCombination therapy specific for genotypes; includes sofosbuvir/velpatasvir, glecaprevir/pibrentasvir
Varicella ZosterDroplet, and contact infectionCommonly in children but can occur in any age group. Reactivation common in immunocompromisedErosive disease of the stomach and intestines, motility problemsClinical diagnosis, but RNA PCR is used for atypical presentationsAcyclovir, valacyclovir, and brivudin
Epstein-Barr virusContact with bodily fluids, especially saliva; sexual transmission, blood transfusion, organ transplantationIndividuals aged 15-24 yrGastritis, Enteritis, esophageal disorders, and gastric cancerMostly clinical diagnosis but can be diagnosed by serologySymptomatic treatment, acyclovir in some cases
HHV-8Sexual transmission, contact with saliva, blood transfusion, and organ transplantationAll age groupsMaculopapular and polypoid lesions of the GI tractEndoscopy and biopsyRadiation, intralesional chemotherapy, or systemic chemotherapy with liposomal doxorubicin and paclitaxel
HPVSexual transmission-oral, vaginal, anal sex15-49 yrOropharyngeal, esophageal, gastric, colorectal, and anal cancersCytology and viral testingCancer-specific treatment